Lisa Wilson | Investor Relations |
Scott Tarriff | President and Chief Executive Officer |
Brian Cahill | Chief Financial Officer |
Mike Greenberg | Vice President of Medical Affairs |
Lachlan Hanbury-Brown | William Blair |
Brandon Folkes | Cantor Fitzgerald |
David Amsellem | Piper Sandler |
Good morning, everyone. My name is Todd and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals First Quarter 2023 Financial Results. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer period.